Published in Mayo Clin Proc on April 01, 2014
Melanoma resistance: a bright future for academicians and a challenge for patient advocates. Mayo Clin Proc (2014) 1.57
Elevated Serum Level of IL-35 Associated with the Maintenance of Maternal-Fetal Immune Tolerance in Normal Pregnancy. PLoS One (2015) 0.79
Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics. Front Immunol (2015) 0.76
Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract. Am J Reprod Immunol (2016) 0.75
Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes? J Am Coll Surg (2017) 0.75
Sex Drives Dimorphic Immune Responses to Viral Infections. J Immunol (2017) 0.75
Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration-approved systemic therapies. J Am Acad Dermatol (2016) 0.75
Regulatory B Cells in Pregnancy: Lessons from Autoimmunity, Graft Tolerance, and Cancer. Front Immunol (2017) 0.75
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med (2013) 18.08
Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med (2013) 17.53
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med (2003) 7.35
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 5.85
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell (2007) 5.09
Sex differences in autoimmune disease. Nat Immunol (2001) 5.08
The complex role of estrogens in inflammation. Endocr Rev (2007) 4.07
Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev (1998) 3.82
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol (1994) 3.79
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell (2003) 3.66
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem (1996) 3.53
Immunology of placentation in eutherian mammals. Nat Rev Immunol (2006) 3.43
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol (2008) 3.29
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Influence of gender on the outcome of severe sepsis: a reappraisal. Chest (2007) 2.96
Immune resistance orchestrated by the tumor microenvironment. Immunol Rev (2006) 2.83
Dopamine as a prolactin (PRL) inhibitor. Endocr Rev (2001) 2.77
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 2.73
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol (2007) 2.72
Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest (2004) 2.72
Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med (2000) 2.68
Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol (1993) 2.65
Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol (2002) 2.60
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A (2013) 2.47
Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res (1997) 2.46
A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem (2004) 2.42
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update (2006) 2.15
Superior survival of young women with malignant melanoma. Am J Surg (1998) 2.09
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res (2011) 2.07
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA (1995) 2.03
Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol (1995) 1.99
Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood (2011) 1.85
Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab (2002) 1.85
Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol (2003) 1.79
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest (2002) 1.76
Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol (2013) 1.71
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell (2002) 1.71
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer (2009) 1.70
Sex affects immunity. J Autoimmun (2012) 1.68
Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res (2006) 1.67
Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol (2009) 1.67
The melanoma epidemic: res ipsa loquitur. Oncologist (2003) 1.66
CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab (2004) 1.64
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab (1996) 1.64
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol (2003) 1.45
Sexual hormones in human skin. Horm Metab Res (2007) 1.43
ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab (1996) 1.41
Endocrine influences on survival from malignant melanoma. Cancer (1978) 1.40
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab (2002) 1.37
Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood (2003) 1.35
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer. J Immunother (2012) 1.32
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol (2009) 1.32
Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J (2006) 1.29
Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol (2009) 1.28
Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol (2004) 1.26
Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci (2007) 1.26
Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc (2009) 1.25
Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma. Clin Cancer Res (2009) 1.25
Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online (2008) 1.25
Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. J Immunol (2008) 1.24
Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol (2003) 1.22
Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr Top Microbiol Immunol (2006) 1.22
Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett (2005) 1.19
"Antimyeloangiogenic" therapy for cancer by inhibiting PlGF. Clin Cancer Res (2009) 1.18
Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol (2011) 1.18
Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett (1999) 1.17
Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol (2010) 1.17
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? J Transl Med (2009) 1.15
The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer (2000) 1.15
Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol (2010) 1.15
Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res (2002) 1.13
Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J Immunol (2005) 1.12
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol (2010) 1.10
Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition. J Clin Endocrinol Metab (2012) 1.09
Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol (2006) 1.07
Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation. Endocrinology (2006) 1.07
Regulation of prolactin receptor levels and activity in breast cancer. J Mammary Gland Biol Neoplasia (2008) 1.07
Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly (2010) 1.06
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010). Oncologist (2008) 1.05
Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci (2007) 1.05
Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci (1999) 1.03
hCG, the wonder of today's science. Reprod Biol Endocrinol (2012) 1.03
Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control (2008) 1.03
Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol (2002) 1.02
The gonadotropins: tissue-specific angiogenic factors? Mol Cell Endocrinol (2007) 1.02
Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity (2007) 1.01
Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol (2003) 1.00
Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol (1997) 1.00